flumazenil has been researched along with Cerebral Palsy in 2 studies
Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.
Cerebral Palsy: A heterogeneous group of nonprogressive motor disorders caused by chronic brain injuries that originate in the prenatal period, perinatal period, or first few years of life. The four major subtypes are spastic, athetoid, ataxic, and mixed cerebral palsy, with spastic forms being the most common. The motor disorder may range from difficulties with fine motor control to severe spasticity (see MUSCLE SPASTICITY) in all limbs. Spastic diplegia (Little disease) is the most common subtype, and is characterized by spasticity that is more prominent in the legs than in the arms. Pathologically, this condition may be associated with LEUKOMALACIA, PERIVENTRICULAR. (From Dev Med Child Neurol 1998 Aug;40(8):520-7)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Park, HJ | 2 |
| Kim, CH | 1 |
| Park, ES | 2 |
| Park, B | 1 |
| Oh, SR | 1 |
| Oh, MK | 1 |
| Park, CI | 2 |
| Lee, JD | 2 |
| Kim, DG | 1 |
| Rha, DW | 1 |
| Kim, EY | 1 |
| Kim, DI | 1 |
| Kim, JJ | 1 |
| Yun, M | 1 |
| Ryu, YH | 1 |
| Lee, J | 1 |
| Jeong, JM | 1 |
| Lee, DS | 1 |
| Lee, MC | 1 |
2 other studies available for flumazenil and Cerebral Palsy
| Article | Year |
|---|---|
Increased GABA-A receptor binding and reduced connectivity at the motor cortex in children with hemiplegic cerebral palsy: a multimodal investigation using 18F-fluoroflumazenil PET, immunohistochemistry, and MR imaging.
Topics: Adolescent; Animals; Cerebral Palsy; Child; Female; Flumazenil; Gene Expression Regulation; Hemipleg | 2013 |
Assessment of regional GABA(A) receptor binding using 18F-fluoroflumazenil positron emission tomography in spastic type cerebral palsy.
Topics: Adolescent; Adult; Binding Sites; Brain Stem; Cerebral Palsy; Child; Female; Flumazenil; Fluorine Ra | 2007 |